3628 results for «701»
3628 results
Complications of mitral TEER
18 Nov 2025 – From PCR London Valves 2025
This session addresses complications associated with mitral transcatheter edge-to-edge repair (TEER), showcasing innovative bailout methods such as snare-assisted retrieval of undeployed devices, managing leaflet perforations with latest-generation devices, cases of valve-adjacent tears, mechanical support considerations when pumps fail, and the clinical impact of iatrogenic fossa ovalis...
TAVI-in-TAVI - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session explores the evolving field of TAVI-in-TAVI interventions, presenting complex cases such as transfemoral TAVI-in-TAVI for degenerated transapical clip-fixed valves in transplanted hearts, management of very late TAVI migration in Bentall de Bono patients, TAVI for degenerated Evolut R valves, stepwise approaches to coronary protection...
Curious TAVI scenarios - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session examines unusual and challenging clinical scenarios following TAVI, including presentations of cyanosis, evolving valvular defects such as growing paravalvular holes, atypical imaging findings, paradoxical transvalvular gradients switching from aortic regurgitation to stenosis resolved by postdilatation, and bicoronary protection techniques in patients with low coronary...
TAVI - Haemodynamic performance and valve durability
18 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of haemodynamic performance and valve durability following transcatheter aortic valve implantation (TAVI). Attendees will gain a comprehensive understanding of the differences between invasive and echocardiographic gradients post-TAVI, evaluate the haemodynamic profiles of various transcatheter valve platforms, and appreciate their implications...
From innovation to intervention: optimising procedural techniques in tricuspid TEER
17 Nov 2025 – From PCR London Valves 2025
Explore advanced strategies for tricuspid TEER in this PCR London Valves 2025 session.
Through real-world cases and interactive simulation, learn how to optimise outcomes in complex tricuspid anatomy, manage challenges posed by pacemaker leads, and enhance procedural efficiency using the TriClip G5 device.
Gain practical insights on clipping...
Getting the full potential of the supra-annular valve in a changing landscape
16 Nov 2025 – From PCR London Valves 2025
This session explores the evolving landscape of transcatheter aortic valve implantation (TAVI) with a focus on supra-annular valve technology. It covers techniques for achieving commissural alignment, considerations for small aortic annuli, and advantages in treating bicuspid aortic valve disease, supported by clinical data and illustrative cases.
Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV
17 Nov 2025 – From PCR London Valves 2025
This session addresses emerging topics in structural heart disease by examining patient-centered solutions such as EVOQUE transcatheter tricuspid valve replacement (TTVR) and SAPIEN transcatheter heart valve-in-heart valve (THV-in-THV) procedures. It covers the latest data from Europe on redo TAVI, lifetime management strategies beginning with initial prosthesis...
How to optimise TAVI outcomes in extreme patient anatomies?
16 Nov 2025 – From PCR London Valves 2025
Explore strategies to optimise TAVI outcomes in patients with extreme anatomies in this PCR London Valves 2025 session.
Through case-based discussions, the session addresses challenges in small annular anatomy, approaches for large annuli, and strategies to ensure optimal lifetime management for younger TAVI patients. Learn practical tips...
Just CINCH - Indirect annuloplasty for secondary mitral regurgitation in heart failure patients
16 Nov 2025 – From PCR London Valves 2025
This session provides a detailed review of indirect annuloplasty as an interventional treatment for secondary mitral regurgitation in heart failure patients, with a focus on the landmark EMPOWER trial. Learn about patient selection optimisation, procedural considerations involving the coronary sinus and left circumflex artery, and future...
LAA closure is evolving: are you ready?
17 Nov 2025 – From PCR London Valves 2025
This session addresses the evolving landscape of left atrial appendage (LAA) closure in stroke prevention for atrial fibrillation patients. It reviews unmet clinical needs, evaluates the latest evidence and guideline recommendations, and identifies patient populations that benefit most from LAA closure, with discussions on balancing efficacy...
Mastering complex TAVI: overcoming key clinical challenges and achieving optimal outcomes with the Evolut FX+
17 Nov 2025 – From PCR London Valves 2025
This session offers an in-depth review of complex TAVI cases, focusing on overcoming clinical challenges and achieving optimal outcomes with the Evolut FX+ device. Participants will learn about recent advances in TAVI indications for younger and asymptomatic patients, strategies for managing TAV in surgical aortic valve...
Mastering mitral and tricuspid TEER: clinical strategies in patients with complex anatomy
17 Nov 2025 – From PCR London Valves 2025
Find out more about advanced mitral and tricuspid TEER techniques for patients with challenging anatomy. This PCR London Valves 2025 session highlights real-world approaches from the Asia Pacific region, including consensus recommendations from the Asian Pacific Society of Cardiology, strategies for simultaneous mitral TEER and left...
Meet with Myval THV series with real-world case-based learning
17 Nov 2025 – From PCR London Valves 2025
Discover the latest insights from the Myval THV series in this session from PCR London Valves 2025. Through real-world, case-based learning, the session explores lifetime management strategies for TAVI patients, the clinical relevance of intermediate and extra-large valve sizing, and the impact of foreshortening on accurate...
A new era for aortic regurgitation: how new guidelines and dedicated devices for AR will redefine treatment
18 Nov 2025 – From PCR London Valves 2025
This session examines the evolving treatment landscape for aortic regurgitation (AR) in light of new ESC guidelines and dedicated devices such as the JenaValve Trilogy System. It provides an in-depth look at refined diagnosis, optimized treatment strategies, and presents real-world data and clinical cases that highlight...
Mitral regurgitation: from guidelines to clinical practice
16 Nov 2025 – From PCR London Valves 2025
This LIVE case symposium brings mitral regurgitation guidelines into real clinical practice. Through step-by-step patient demonstrations and insightful discussion, the session explores how recommendations guide decision-making in ventricular and atrial secondary MR, how the heart team tailors therapy to individual anatomy and comorbidities, and how device iterations...
Advancing structural heart with 3D ICE and device guidance
17 Nov 2025 – From PCR London Valves 2025
This PCR London Valves 2025 session explores how 3D TEE, 3D intracardiac echocardiography (ICE), and DeviceGuide technology sharpen procedural accuracy, strengthen operator confidence, and streamline decision-making in real time.
You’ll see how clearly defined team roles enhance both safety and efficiency, and how thoughtful workflow integration can reduce...
Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice
17 Nov 2025 – From PCR London Valves 2025
Discover the essential takeaways from the Myval THV series for improving TAVI outcomes. Learn from high-volume operators how pre-procedural planning, imaging, and sizing rationale guide optimal patient management. See step-by-step implantation of the next-gen Myval Octapro+, including the OctaAlign technique, and understand how precise deployment and...
Open design, confident delivery - How a novel LAA closure device provides predictable outcomes in complex anatomical settings
16 Nov 2025 – From PCR London Valves 2025
This session highlights a novel left atrial appendage (LAA) closure device featuring an open-cage design that delivers predictable clinical and procedural outcomes. It discusses the device's advantages in managing complex anatomical variations and presents implantation techniques across diverse anatomies to improve safety and efficacy.
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
Planning a lifetime of care in younger patients with Evolut FX+: from index valve to future options
17 Nov 2025 – From PCR London Valves 2025
Watch this PCR London Valves 2025 session to take a deep look at the latest evidence in low-risk aortic stenosis, the durability of contemporary valves, and how anatomy — especially in women and patients with small annuli — shapes long-term strategy.
From index TAVI with Evolut FX+...
